CHELSEA NEWSOME: Open Payments
NPI 1063055762 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 40 payments from 14 companies in 2025. Trend: 2023 $74 · 2024 $686 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $191 |
| Otsuka America Pharmaceutical, Inc. | 6 | $123 |
| Vanda Pharmaceuticals Inc. | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| AtriCure, Inc. | 4 | $66 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
Products named: VRAYLAR, REXULTI, LEQVIO, HETLIOZ, ABILIFY ASIMTUFII, INJECTAFER, FANAPT, INGREZZA.
Industry payments across TN — which companies pay providers there.
